CD19 and neoplasm: Eight days post-tumor cell injection, the tumor-bearing mice were randomized into three groups (n = 6) and i.p injected with PBS, T cells electroporated with an irrelevant anti-CD19 CAR, or T cells electroporated with anti-EpCAM RNA CAR twice a week for 3 weeks.